Skip to main content

‘Ethan Lippmann’

New Extracellular Vesicle Research Center launches; NSF grant is an early success

Jul. 12, 2021—On July 1, the Program for Extracellular Vesicle Research became one of the nine official centers and institutes associated with the School of Medicine Basic Sciences. The Center for Extracellular Vesicle Research is led by Professor of Cell and Developmental Biology Alissa Weaver, who holds the Cornelius Vanderbilt Chair and also led the center’s previous incarnation as a program....

Read more


Trans-institutional collaboration receives $2 million BRAIN Initiative grant, developing brain organoids to map neurological development

Feb. 3, 2021—Vivian Gama, assistant professor of cell and developmental biology, and Leon Bellan, associate professor of mechanical engineering and biomedical engineering, have won a $2.3 million, three-year grant from the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies Initiative. Vivian Gama Leon Bellan (Vanderbilt University) The researchers will be developing three-dimensional brain organoids and...

Read more


Brunger leads $1.5 million NSF project to develop advanced brain organoids

Jan. 7, 2021—Vanderbilt engineers have received a $1.49 million National Science Foundation grant to advance the science of organoids with cells that organize themselves and mimic development of human brain structures. Organoids are lab-produced groups of cells that serve as research models for human physiology in development and disease, including design and testing of drugs and other...

Read more


Engineering lab returns during Vanderbilt’s Research Ramp-up to advance research in neurodegeneration

Nov. 16, 2020—The lab of Ethan Lippmann, assistant professor of chemical and biomolecular engineering and biomedical engineering, seeks to model, understand, and ultimately treat neurodegeneration, focusing primarily on the blood-brain barrier, a border of protective blood vessels found in the brain. Before the COVID-19 pandemic, Lippmann’s team in the Neurovascular Engineering and Therapeutic Design Laboratory was firing...

Read more


NSF seed grant supports biomanufacturing of new drug delivery technologies

Oct. 2, 2020—Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no side effects. The ability to engineer the...

Read more


Adams to lead TIPs-funded, soldier-inspired innovation hub

Jun. 30, 2020—Sanchez, Valentine awarded VU Discovery Grants A new innovation incubator will amplify existing collaborations among researchers and soldiers, building on Vanderbilt’s partnership agreement with Army Futures Command. The project, Soldier-Inspired Innovation Incubator for Discovering Research-Based Solutions, is one of six cross-disciplinary programs to be funded by Vanderbilt’s Trans-Institutional Programs (TIPs) initiative, a hallmark of the...

Read more


Lippmann awarded NSF CAREER grant to study mechanics of blood-brain barrier

Apr. 3, 2019—Ethan Lippmann, assistant professor of chemical and biomolecular engineering, has received a National Science Foundation Faculty Early Career Development grant. The five-year, $401,650 grant—Deconstructing Neurovascular Mechanobiology—begins July 1, 2019. Lippmann studies changes in brain vascular physiology due to aging or disease. “The goal of this award is to investigate the hypothesis that changes in the...

Read more


First step toward model brain: turning iPSCs into working blood-brain barrier

Feb. 21, 2019—Vanderbilt University engineering researchers took a major step toward building a “brain in a dish:” They cultured induced pluripotent stem cells into a successful three-dimensional blood-brain barrier model. The future of drug testing and disease research lies in creating organoids, or models of human organs, to determine efficacy and potency of medications. Duplicating the endothelial...

Read more